Abcam

Activities: Research & Development

Trending Articles

  1. Merck opens $1bn US vaccine manufacturing centre in Durham, North Carolina The extension aligns with Merck's plant to expand its US pharmaceutical manufacturing footprint, with the company planning to invest another $8bn by 2028
  2. Pfizer integrates Coperion's K-Tron feeders into its German OSD manufacturing plant Pfizer's contained facility in Freiburg, Germany now includes Coperion's K-Tron feeders, which will dose the correct amount of excipients and APIs required for each batch
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Managing waste in the pharmaceutical manufacturing industry With estimates suggesting that pharmaceutical manufacturing companies produce approximately 300 million tons of plastic waste each year, the industry is being put under ever...
  4. dsm-firmenich launches pharmaceutical taste solutions portfolio The range aims to improve the taste and sensory experience of solid, liquid or semi-solid dosage forms
  5. Almac Pharma Services opens doors on £65m new commercial manufacturing facility Centre of excellence is a timely response to emerging pipeline needs in highly potent drug development

Upcoming event

DCAT Week

17–20 March 2025 | Conference | New York, US See all

Related Content

Research & Development

Danaher set to acquire antibody company Abcam

The two companies have entered an agreement whereby Danaher is set to acquire biotechnology company Abcam's shares for $24 per share
Manufacturing

Avacta signs distribution agreement with Abcam

Abcam supplies biological reagents and kits used in a wide range of fields including drug discovery, diagnostics and basic research
Finance

Axol Bioscience and Censo Biotechnologies announce merger

Under the terms of the agreement, Axol CEO, Liam Taylor, and the company’s senior leadership team will take over the management of the combined entity
Finance

Abingdon Health signs co-marketing agreement with Abcam

Under the terms of the agreement, Abcam will be the preferred supplier to Abingdon of gold nanoparticles and custom conjugation reagents and services
Finance

Abcam opens cell engineering facility in Bay Area

This development builds upon Abcam’s previous acquisition of a range of knockout cell lines from Edigene last year
Ingredients

Abcam offers bioactive proteins for drug discovery

Sourcing high-quality proteins with batch-to-batch consistency can be a challenge, as endotoxin levels and/or non-native protein conformations and post-translational modifications can affect safety and performance
Manufacturing

John Baker: life sciences need to address the reproducibility crisis

The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to the patient as early as possible
Subscribe now